The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $33.57

Today's change0.00 0.00%
Updated May 5 4:00 PM EDT. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $33.57

Today's change0.00 0.00%
Updated May 5 4:00 PM EDT. Delayed by at least 15 minutes.

Pfizer Inc closed at (U.S.)$33.57.

Over the last five days, shares have gained 2.01% and 4.00% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $33.57
  • High--
  • Low--
  • Bid / Ask(U.S.) $33.18 / (U.S.) $33.89
  • YTD % change+4.00%
  • Volume0
  • Average volume (10-day)34,190,804
  • Average volume (1-month)51,067,494
  • Average volume (3-month)44,425,975
  • 52-week range(U.S.) $28.25 to (U.S.) $36.46
  • Beta0.85
  • Trailing P/E30.20×
  • P/E 1 year forward14.01×
  • Forward PEG1.97×
  • Indicated annual dividend(U.S.) $1.20
  • Dividend yield3.57%
  • Trailing EPS(U.S.) $1.11
Updated May 5 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 27, 201509/27/2015Jun 28, 201506/28/2015Mar 29, 201503/29/2015
Revenue14,04712,08711,85310,864
Total other revenue--------
Total revenue14,04712,08711,85310,864
Gross profit10,6759,8809,6909,035
Total cost of revenue3,3722,2072,1631,829
Total operating expense14,0799,2188,0997,701
Selling / general / administrative5,0483,2703,3863,104
Research & development2,3481,7221,7341,885
Depreciation / amortization980937872940
Interest expense (income), net operating--------
Unusual expense (income)1,5571,286290170
Other operating expenses, total774-204-346-227
Operating income-322,8693,7543,163
Interest income (expense), net non-operating-335-278-278-309
Gain (loss) on sale of assets23519175
Other--------
Income before tax-3552,6973,5393,082
Income after tax-1672,1302,6342,376
Income tax, total-188567905706
Net income-1732,1292,6262,375
Total adjustments to net income1100
Net income before extra. items-1702,1212,6252,370
Minority interest-3-9-9-6
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1692,1222,6252,370
Inc. avail. to common incl. extra. items-1722,1302,6262,375
Diluted net income-1722,1302,6262,375
Dilution adjustment--000
Diluted weighted average shares6,1766,2436,2436,292
Diluted EPS excluding extraordinary itemsvalue per share-0.030.340.420.38
Dividends per sharevalue per share0.280.280.280.28
Diluted normalized EPSvalue per share0.210.510.460.37